5XRA image
Deposition Date 2017-06-08
Release Date 2017-07-12
Last Version Date 2024-11-20
Entry Detail
PDB ID:
5XRA
Title:
Crystal structure of the human CB1 in complex with agonist AM11542
Biological Source:
Method Details:
Experimental Method:
Resolution:
2.80 Å
R-Value Free:
0.25
R-Value Work:
0.23
R-Value Observed:
0.23
Space Group:
P 21 2 21
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Cannabinoid receptor 1,Flavodoxin,Cannabinoid receptor 1
Gene (Uniprot):DVU_2680, CNR1
Mutations:T210A, E273K, T283V,Y1098W,R340E
Chain IDs:A
Chain Length:438
Number of Molecules:1
Biological Source:Homo sapiens, Desulfovibrio vulgaris (strain Hildenborough / ATCC 29579 / DSM 644 / NCIMB 8303)
Primary Citation
Crystal structures of agonist-bound human cannabinoid receptor CB1
Nature 547 468 471 (2017)
PMID: 28678776 DOI: 10.1038/nature23272

Abstact

The cannabinoid receptor 1 (CB1) is the principal target of the psychoactive constituent of marijuana, the partial agonist Δ9-tetrahydrocannabinol (Δ9-THC). Here we report two agonist-bound crystal structures of human CB1 in complex with a tetrahydrocannabinol (AM11542) and a hexahydrocannabinol (AM841) at 2.80 Å and 2.95 Å resolution, respectively. The two CB1-agonist complexes reveal important conformational changes in the overall structure, relative to the antagonist-bound state, including a 53% reduction in the volume of the ligand-binding pocket and an increase in the surface area of the G-protein-binding region. In addition, a 'twin toggle switch' of Phe2003.36 and Trp3566.48 (superscripts denote Ballesteros-Weinstein numbering) is experimentally observed and appears to be essential for receptor activation. The structures reveal important insights into the activation mechanism of CB1 and provide a molecular basis for predicting the binding modes of Δ9-THC, and endogenous and synthetic cannabinoids. The plasticity of the binding pocket of CB1 seems to be a common feature among certain class A G-protein-coupled receptors. These findings should inspire the design of chemically diverse ligands with distinct pharmacological properties.

Legend

Protein

Chemical

Disease

Primary Citation of related structures